Cosmos Health targets 2028 C-Scrub, C-Sept revenue of about $7.4 million

Cosmos Health Inc

Cosmos Health Inc

COSM

0.00
  • Cosmos Health set a three-year outlook for C-Scrub and C-Sept, following combined annualized sales above USD 1.5 million in the UK, Greece.
  • Targets USD 2.5 million revenue in 2026 with gross profit about USD 1.8 million, implying roughly 72% gross margin.
  • Forecasts USD 4.2 million revenue in 2027 with gross profit about USD 3 million.
  • Sees USD 7.4 million revenue in 2028 with gross profit about USD 5.3 million.
  • Outlook assumes EU market expansion; target could rise if C-Scrub scales into animal healthcare.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmos Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606120929OMX_____CNEWS_EN_GNW9746109_en) on June 12, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.